Merck, Kelun-Biotech ink pact to develop seven investigational preclinical ADC for cancer treatment Ruchika Sharma25 Dec 2022 5:30 AMKelun-Biotech will receive an upfront payment of $175 million from Merck.
Merck secures USFDA priority review for PADCEV with KEYTRUDA for treatment of Urothelial Cancer Ruchika Sharma22 Dec 2022 9:51 AMPADCEV (enfortumab vedotin-ejfv) is a first-in-class antibody-drug conjugate (ADC) that is directed against Nectin-4, a protein located on the surface...
Centre deliberates on HPV vaccine introduction in national immunisation programme next year Ruchika Sharma19 Dec 2022 6:52 AMThe government advisory panel NTAGI has also given its go-ahead for the inclusion of CERVAVAC in the public immunisation programme
S pneumoniae infection treatment: DCGI nod to Biological E 14-valent paediatric Pneumococcal Conjugate Vaccine Ruchika Sharma17 Dec 2022 6:03 AMBE’s PCV14 is comparable in terms of serotype coverage for infants to the two globally approved pneumococcal conjugate vaccines Prevenar13 and Merck’s...
Merck commences tender offer to purchase Imago BioSciences Ruchika Sharma13 Dec 2022 5:45 AMRahway: Merck, known as MSD outside of the United States and Canada, has announced that it has commenced through a subsidiary, a cash tender offer to...
French drug agency under investigation over Merck thyroid drug Levothyrox Ruchika Sharma8 Dec 2022 7:00 AMThe plaintiffs said Merck's decision to remove lactose from the drug to make it easier to handle had resulted in side effects such as memory loss,...
Merck hopes to patent subcutaneous version of blockbuster cancer drug Keytruda Ruchika Sharma3 Dec 2022 9:01 AMMerck's patents on the subcutaneous version of Keytruda could protect that formulation until at least 2040, according to Tahir Amin, co-founder of...
Merck to purchase Imago BioSciences for USD 1.35 billion to expand blood disorder drugs portfolio Ruchika Sharma22 Nov 2022 7:00 AMImago’s lead candidate bomedemstat (IMG-7289), an investigational orally available lysine-specific demethylase 1 (LSD1) inhibitor, is currently being...
Merck lifts full-year forecast as cancer immunotherapy Keytruda sales soar Ruchika Sharma29 Oct 2022 8:00 AMMerck has been looking to pursue deals to protect itself from an eventual revenue loss as Keytruda patents begin to expire toward the end of the...
Merck elects Robert M Davis as new Chairman Ruchika Sharma28 Oct 2022 7:00 AMDavis, who currently serves as president and chief executive officer, became Merck’s president in April 2021.
Merck under formal investigation in France over Thyroid Drug Levothyrox Ruchika Sharma20 Oct 2022 9:00 AMParis: Drugmaker Merck said on Wednesday it had been placed under formal investigation by a French court for possibly issuing misleading information...
Merck to develop personalized cancer vaccine in collaboration with Moderna Ruchika Sharma13 Oct 2022 6:45 AMUnder the agreement, originally established in 2016 and amended in 2018, Merck will pay Moderna $250 million to exercise its option for personalized...
